Internal Medicine, Infectious Disease · Chicago, IL
NPI
1366552952
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2020 W Harrison St
Chicago, IL, 60612
Phone (312) 572-4575
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,371
71 services
Medicare patients, 2024
29
Average age 64
Drug cost, 2024
$2.5M
1,491 prescriptions
Company payments, 2024
$3,058
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gregory D Huhn was code 99214 (office e&m - established), 45 times for 19 patients. In total Gregory D Huhn billed 71 services in 6 codes, and Medicare paid $5,371.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 45 | 19 | $68.31 | $3,074 |
By year: 2022 $8,891 for 150 services; 2023 $4,961 for 73 services; 2024 $5,371 for 71 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gregory D Huhn prescribed most often to Medicare patients was Cabenuva (Cabotegravir/Rilpivirine), with 157 prescriptions and refills. In total Gregory D Huhn wrote 1,491 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cabenuva Cabotegravir/Rilpivirine | 157 | 281 | 31 | $1.1M |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 118 | 118 | 17 | $491K |
| Descovy Emtricitabine/Tenofov Alafenam | 77 | 77 | Under 11 | $185K |
| Atorvastatin Calcium Generic | 72 | 114 | 16 | $535 |
| Enalapril Maleate Generic | 60 | 72 | Under 11 | $714 |
| Tivicay Dolutegravir Sodium | 57 | 57 | Under 11 | $139K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 56 | 60 | 12 | $2,198 |
| Prezcobix Darunavir/Cobicistat | 51 | 51 | Under 11 | $132K |
| Gabapentin Generic | 48 | 48 | Under 11 | $300 |
| Metformin Hcl Generic | 45 | 55 | Under 11 | $270 |
| Dovato Dolutegravir Sodium/Lamivudine | 29 | 29 | Under 11 | $96K |
| Xarelto Rivaroxaban | 24 | 28 | Under 11 | $10K |
| Pifeltro Doravirine | 22 | 22 | Under 11 | $41K |
| Rosuvastatin Calcium Generic | 22 | 24 | Under 11 | $456 |
| Jardiance Empagliflozin | 21 | 25 | Under 11 | $9,227 |
Brand drugs: 743 claims; generic drugs: 731 claims; opioid claims: 34.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Gregory D Huhn $3,058 ($3,058 in general payments such as food, travel and fees) from 3 companies. The largest payer was ViiV Healthcare Company with $2,964.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.